Skip to main content
Journal of Virology logoLink to Journal of Virology
. 1984 Jun;50(3):922–928. doi: 10.1128/jvi.50.3.922-928.1984

Guanidine-resistant poliovirus mutants produce modified 37-kilodalton proteins.

K Anderson-Sillman, S Bartal, D R Tershak
PMCID: PMC255754  PMID: 6328023

Abstract

Eighteen spontaneous, guanidine-resistant mutants of poliovirus were obtained by plaque selection. Isoelectric focusing demonstrated charge changes in a 37-kilodalton protein, pX, among three of the mutants. The precursor of pX, NCVP5b , also exhibited charge changes among the three mutants. pX of 12 mutants was also examined by peptide mapping with Staphylococcus aureus V8 protease. Nine of the mutants presented modified maps, and seven of these maps were identical. The demonstration of mutational changes in pX in 12 of 18 mutants suggests a role for this protein in determining the guanidine trait of poliovirus and corroborates studies with foot-and-mouth disease virus.

Full text

PDF
922

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. CROWTHER D., MELNICK J. L. Studies of the inhibitory action of guanidine on poliovirus multiplication in cell cultures. Virology. 1961 Sep;15:65–74. doi: 10.1016/0042-6822(61)90078-2. [DOI] [PubMed] [Google Scholar]
  2. Caliguiri L. A., Tamm I. Action of guanidine on the replication of poliovirus RNA. Virology. 1968 Jul;35(3):408–417. doi: 10.1016/0042-6822(68)90219-5. [DOI] [PubMed] [Google Scholar]
  3. Caliguiri L. A., Tamm I. The role of cytoplasmic membranes in poliovirus biosynthesis. Virology. 1970 Sep;42(1):100–111. doi: 10.1016/0042-6822(70)90242-4. [DOI] [PubMed] [Google Scholar]
  4. Cleveland D. W., Fischer S. G., Kirschner M. W., Laemmli U. K. Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis. J Biol Chem. 1977 Feb 10;252(3):1102–1106. [PubMed] [Google Scholar]
  5. Cole C. N., Baltimore D. Defective interfering particles of poliovirus. II. Nature of the defect. J Mol Biol. 1973 May 25;76(3):325–343. doi: 10.1016/0022-2836(73)90508-1. [DOI] [PubMed] [Google Scholar]
  6. Cole C. N., Smoler D., Wimmer E., Baltimore D. Defective interfering particles of poliovirus. I. Isolation and physical properties. J Virol. 1971 Apr;7(4):478–485. doi: 10.1128/jvi.7.4.478-485.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cooper P. D., Wentworth B. B., McCahon D. Guanidine inhibition of poliovirus: a dependence of viral RNA synthesis on the configuration of structural protein. Virology. 1970 Mar;40(3):480–493. doi: 10.1016/0042-6822(70)90191-1. [DOI] [PubMed] [Google Scholar]
  8. Dawson W. O. Guanidine inhibits tobacco mosaic virus RNA synthesis at two stages. Intervirology. 1975;6(2):83–89. doi: 10.1159/000149459. [DOI] [PubMed] [Google Scholar]
  9. EAGLE H. Nutrition needs of mammalian cells in tissue culture. Science. 1955 Sep 16;122(3168):501–514. doi: 10.1126/science.122.3168.501. [DOI] [PubMed] [Google Scholar]
  10. Friedman R. M. Basis for variable response of arboviruses to guanidine treatment. J Virol. 1970 Nov;6(5):628–636. doi: 10.1128/jvi.6.5.628-636.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hamann A., Wiegers K. J., Drzeniek R. Isoelectric focusing and 2D-analysis of poliovirus proteins. Virology. 1977 May 1;78(1):359–362. doi: 10.1016/0042-6822(77)90111-8. [DOI] [PubMed] [Google Scholar]
  12. Jacobson M. F., Baltimore D. Morphogenesis of poliovirus. I. Association of the viral RNA with coat protein. J Mol Biol. 1968 Apr 28;33(2):369–378. doi: 10.1016/0022-2836(68)90195-2. [DOI] [PubMed] [Google Scholar]
  13. Koschel K., Wecker E. Early functions of poliovirus. 3. The effect of guanidine on early functions. Z Naturforsch B. 1971 Sep;26(9):940–944. doi: 10.1515/znb-1971-0917. [DOI] [PubMed] [Google Scholar]
  14. LODDO B., FERRARI W., BROTZU G., SPANEDDA A. In vitro inhibition of infectivity of polio viruses by guanidine. Nature. 1962 Jan 6;193:97–98. doi: 10.1038/193097a0. [DOI] [PubMed] [Google Scholar]
  15. LODDO B., MUNTONI S., SPANEDDA A., BROTZU G., FERRARI W. Guanidine conditioned infectivity of ribonucleic acid extracted from a strain of guanidine-dependent polio-1-virus. Nature. 1963 Jan 19;197:315–315. doi: 10.1038/197315a0. [DOI] [PubMed] [Google Scholar]
  16. Laemmli U. K., Favre M. Maturation of the head of bacteriophage T4. I. DNA packaging events. J Mol Biol. 1973 Nov 15;80(4):575–599. doi: 10.1016/0022-2836(73)90198-8. [DOI] [PubMed] [Google Scholar]
  17. Lee Y. S., Yajima Y., Nonoyama M. Mechanism of infection by Epstein-Barr virus. II. Comparison of viral DNA from HR-1 and superinfected Raji cells by restriction enzymes. Virology. 1977 Aug;81(1):17–24. doi: 10.1016/0042-6822(77)90054-x. [DOI] [PubMed] [Google Scholar]
  18. Lundquist R. E., Sullivan M., Maizel J. V., Jr Characterization of a new isolate of poliovirus defective interfering particles. Cell. 1979 Nov;18(3):759–769. doi: 10.1016/0092-8674(79)90129-6. [DOI] [PubMed] [Google Scholar]
  19. Nick H., Ahl R. Inhibitors of foot-and-mouth disease virus. Temperature-dependence of the effect of guanidine on virus growth. Arch Virol. 1976;52(1-2):71–83. doi: 10.1007/BF01317866. [DOI] [PubMed] [Google Scholar]
  20. Noble J., Levintow L. Dynamics of poliovirus-specific RNA synthesis and the effects of inhibitors of virus replication. Virology. 1970 Mar;40(3):634–642. doi: 10.1016/0042-6822(70)90208-4. [DOI] [PubMed] [Google Scholar]
  21. Penman S., Summers D. Effects on host cell metabolism following synchronous infection with poliovirus. Virology. 1965 Dec;27(4):614–620. doi: 10.1016/0042-6822(65)90187-x. [DOI] [PubMed] [Google Scholar]
  22. RIGHTSEL W. A., DICE J. R., McALPINE R. J., TIMM E. A., McLEAN I. W., Jr, DIXON G. J., SCHABEL F. M., Jr Antiviral effect of guanidine. Science. 1961 Aug 25;134(3478):558–559. doi: 10.1126/science.134.3478.558. [DOI] [PubMed] [Google Scholar]
  23. Saunders K., King A. M. Guanidine-resistant mutants of aphthovirus induce the synthesis of an altered nonstructural polypeptide, P34. J Virol. 1982 May;42(2):389–394. doi: 10.1128/jvi.42.2.389-394.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Singer B. S., Morrissett H., Gold L. An electrofocusing system for the analysis of proteins and their genetic variants. Anal Biochem. 1978 Mar;85(1):224–229. doi: 10.1016/0003-2697(78)90293-2. [DOI] [PubMed] [Google Scholar]
  25. Tershak D. R. Guanidine-resistant defective interfering particles of poliovirus. J Virol. 1982 Feb;41(2):615–625. doi: 10.1128/jvi.41.2.615-625.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Tershak D. R. Inhibition of poliovirus polymerase by guanidine in vitro. J Virol. 1982 Jan;41(1):313–318. doi: 10.1128/jvi.41.1.313-318.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Varma J. P. Inhibition of tobacco necrosis virus by guanidine carbonate. Virology. 1968 Oct;36(2):305–308. doi: 10.1016/0042-6822(68)90149-9. [DOI] [PubMed] [Google Scholar]
  28. Yin F. H. Involvement of viral procapsid in the RNA synthesis and maturation of poliovirus. Virology. 1977 Oct 15;82(2):299–307. doi: 10.1016/0042-6822(77)90005-8. [DOI] [PubMed] [Google Scholar]
  29. Yin F. H., Lomax N. B. Host range mutants of human rhinovirus in which nonstructural proteins are altered. J Virol. 1983 Nov;48(2):410–418. doi: 10.1128/jvi.48.2.410-418.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES